![Sourav Kole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sourav Kole
Director/Board Member at
Paros Bio, Inc.
Profile
Sourav Kole is the founder of Xenocor, Inc. (2011).
Current jobs include Director of the Board of Directors at Mindimmune Therapeutics, Inc. (2022), Director at Paros Bio, Inc. (2022), Board Member at Cerevance, Inc. (2022), Board Member at NeuroTherapia, Inc. (2022), Board Member at QurAlis Corp.
(2022), Board Member at Therini Bio, Inc. (2022), and Board Member at Libra Therapeutics, Inc. (2022).
Former jobs include Director at Reservoir Neuroscience, Inc. and Managing Director at Dolby Family Ventures LLC.
Education includes a graduate degree from the University of Utah and an undergraduate degree from The Pennsylvania State University.
Sourav Kole active positions
| Companies | Position | Start |
|---|---|---|
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Director/Board Member | 01/01/2022 |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Director/Board Member | 01/01/2022 |
Libra Therapeutics, Inc.
 Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Director/Board Member | 01/01/2022 |
Cerevance, Inc.
 Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Director/Board Member | 01/01/2022 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Director/Board Member | 01/01/2022 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Director/Board Member | 01/01/2022 |
Mindimmune Therapeutics, Inc.
 Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Director/Board Member | 01/01/2022 |
Former positions of Sourav Kole
| Companies | Position | End |
|---|---|---|
Xenocor, Inc.
 Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Founder | 31/12/2015 |
Reservoir Neuroscience, Inc.
 Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Director/Board Member | - |
| ░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Training of Sourav Kole
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dolby Family Ventures LLC
 Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures invests in companies located across the globe primarily in the United States. The firm focuses on life sciences and technology sectors such as precision neuroscience, life sciences platforms, climate, digital and aerospace. It participates in pre-seed, seed, early and later stage transactions. The firm also makes follow-on investments. | Finance |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Health Technology |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Reservoir Neuroscience, Inc.
Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics for blood-brain based diseases | Health Technology |
Libra Therapeutics, Inc.
Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases | Health Technology |
Xenocor, Inc.
Xenocor, Inc. Medical SpecialtiesHealth Technology Operates as medical devices company | Health Technology |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Health Technology |
- Stock Market
- Insiders
- Sourav Kole
